• Skip to main content
  • Skip to primary sidebar

SpotGamma™

S&P 500 Stock Market Gamma Trading Levels Based on Options Open Interest

  • About
  • Pricing
  • Academy
  • Resources
    • Tool Demos
    • Case Studies
    • Blog
    • Support Center
    • Free Daily Report
    • Free Trading Tools
      • Options Profit Calculator
      • SPX Gamma Exposure
      • Implied Earnings Moves
      • Volatility Ranking
    • Free Training
    • Report Card
  • Login

Market Analysis

Aug 26 2026

One Stock, 803 ETFs: Why Nvidia Earnings Impacts the Entire S&P 500

Brent Kochuba joined CNBC to discuss Nvidia’s earnings, Salesforce, and how options traders repositioned across bond ETFs after comments from Treasury Secretary Bessent.

Written by SpotGamma · Categorized: Market Analysis · Tagged: earnings, Implied Move, NVDA, S&P 500, salesforce, TLT

Aug 25 2026

NVDA Earnings: The Options Market May Be Underpricing This Move

NVDA reports Wednesday after the close with the options market pricing a 5.5% move — below its 7.4% average realized move over the last 12 quarters. Dealers are short gamma above $220, call skew sits at the 81st percentile, and a distorted term structure opens up a calendar spread setup.

Written by SpotGamma · Categorized: Market Analysis · Tagged: call calendar, dealer gamma, Implied Move, NVDA, SpotGamma blog, volatility

Aug 23 2026

Volatility Has Compressed. What Happens Next?

The S&P 500 pulled back slightly last week, and the market’s recent volatility compression phase appears ready for a reset. With earnings season largely over, both index and single stock volatility have dropped from the elevated levels that prevailed earlier this summer. Our pre-market Founder’s Note on Friday explained how substantial short-options positions cleared with […]

Written by Sherry An · Categorized: Market Analysis, SpotGamma Weekly · Tagged: contango, dealer gamma, forward implied volatility, Gamma Exposure, implied volatility, IWM put skew, Jackson Hole, Kevin Warsh, options positioning, options skew, QQQ call skew, spotgamma weekly, SPX term structure, synthetic gamma

Aug 20 2026

Another SpaceX Unlock, and Why $150 Still Caps the Stock

Roughly 300 million SpaceX shares came on the market Thursday, but no new stock was created and there is no dilution. The binding constraint on SPCX sits higher: call selling at and above spot has left dealers with positive gamma, making $150 the new ceiling.

Written by SpotGamma · Categorized: Market Analysis

Aug 17 2026

Options Exchange Monitor — Week of August 15, 2026 (36 SEC notices, 2 CFTC, 0 EDGAR)

SpotGamma tracks structural and regulatory changes in the U.S. options market: SEC SRO rule filings, CFTC actions, and OCC clearing notices. This update summarizes what changed and why it matters for options traders. Executive Summary OCC STAN Methodology Update (Doc 2026-15928) — APPROVED: The OCC has received SEC approval to incorporate options-implied interest rates as […]

Written by SpotGamma · Categorized: Market Analysis

Aug 17 2026

GEX Levels for SPY, QQQ, ES and NQ: Using Index Gamma in Any Product

How to use GEX levels when you trade SPY, QQQ, or ES/NQ futures: converting SPX and NDX gamma levels between products, why the structure transfers, and what changes for 0DTE and futures sessions.

Written by SpotGamma · Categorized: Market Analysis

Aug 17 2026

How to Trade GEX Levels: A Practical Guide to Gamma-Based Trading

How do you actually trade GEX levels? Reading the gamma regime, using call and put walls as support and resistance, the zero gamma flip point, and how strategies change between positive and negative gamma.

Written by SpotGamma · Categorized: Market Analysis

Aug 17 2026

Free GEX Levels, Charts, and Data: What’s Available and What It’s Actually Worth

Where to find free GEX levels, charts, and data — including SpotGamma’s free SPX gamma exposure tool — plus what free gamma data can and can’t tell you, and when it’s worth paying for more.

Written by SpotGamma · Categorized: Market Analysis

Aug 17 2026

Covered Calls After Assignment: What to Do When the Stock Drops Below Your Cost Basis

Assigned on a put and now the stock is way below your cost basis? The covered-call playbook for underwater shares: strike choice, rolling, when to wait, and when to take the loss.

Written by SpotGamma · Categorized: Market Analysis

Aug 17 2026

Is Selling Options Actually Profitable? The Honest Answer to Theta Gang’s Favorite Question

If selling options beats the market, why doesn’t everyone do it? The variance risk premium, the tail risk that funds it, why professionals do sell premium (differently), and when premium selling fails.

Written by SpotGamma · Categorized: Market Analysis

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 63
  • Go to Next Page »

Primary Sidebar

SpotGamma-Subscriber-Signup-Banner

  • Trade Idea Generation Using Opening Setup
  • Gamma Guy with tastylive: Options Positioning Pins the Index While Tech Names Make Moves
  • Oracle Earnings Preview: $638B AI Backlog vs. an 11.5% Options Implied Move
  • AI Infrastructure Runs Hot into September
  • Doves Fly into August Jobs Report
  • youtube
  • x
  • Privacy Policy
  • Disclaimer
  • Terms & Conditions
  • Support Center
  • Media
  • Contact Us

©2026 TenTen Capital LLC DBA SpotGamma

All SpotGamma materials, information, and presentations are for educational purposes only and should not be considered specific investment advice nor recommendations. Futures, foreign currency and options trading contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing one's financial security or lifestyle. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. Testimonials appearing on this website may not be representative of other clients or customers and is not a guarantee of future performance or success.

View Full Risk Disclosure